Our Company
TAAG Diagnostics, a division of TAAG Genetics, is a molecular diagnostics company that develops, manufactures, and markets tests and systems for genetic analysis in the clinical and industrial markets.
TAAG Diagnostics is changing the way to see molecular testing. Until now molecular testing have been restricted to expensive specialized laboratories operated by highly trained technologist. TAAG Diagnostics’ solutions represent a belief shift in the utility and accessibility of molecular diagnostics.
TAAG Diagnostics is focused on applications where multiplex PCR diagnostic tests could bring significant advantages to our customers, such as multiple pathogens testing in the clinical, food, agricultural and environmental fields.
News
July 20, 2010
TAAG Diagnostics Licenses Molecular Technology to Laboratorio Florida for In Vitro Diagnostic Testing
TAAG Diagnostics, developer of molecular and rapid diagnostic products, announced today that it has signed an end user license agreement (EULA) with Laboratorio Florida (Mexico) for use of the Company’s proprietary technologies in human in vitro diagnostic testing. Under the licensing agreement, Laboratorio Florida will have rights to manufacture and offer services incorporating the TAAG Diagnostics technology. Terms of the EULA include an upfront fee and royalties paid on tests sold using the licensed technology.
July 15, 2010
Clinica Davila incorporates TAAG Diagnostics HPV testing products
Clinica Davila, the larger Chilean private health care center has incorporated TAAG Diagnostics HPV testing products. Since 2010 Clinica Davila has been using TAAG Diagnostics products for detection of bacteria related to sexually transmitted diseases (STD). With the incorporation of this new test, Clinica Davila confirms its commitment with the woman health.